Overview
Developer of AI-powered anti-aging drugs.
Funding
Amounts as reported; USD estimates shown only when they matchListed 3 funding records.
No chartable funding estimates yet.
3 listed records lack a clear date or positive USD estimate for the chart.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| Jul 17, 2026 | Tens of millions of RMB · Seed | Boyu Venture Capital, 九合创投, 星连资本, 砺思资本 | No source link |
Evidence Wujinfangzhou raises tens of millions of RMB in seed financingOn 2026-07-17, according to Xiniu Data, Wujinfangzhou completed seed financing, raising tens of millions of RMB. Investors were lead investor Jiuhe Venture Capital, participating investor Monolith, participating investor Boyu Capital, participating investor Xinglian Capital. The company is a developer of AI-powered anti-aging drugs. Translated source brief, not a quotation. Check the original before citing. Sources · 0
| |||
| Jul 7, 2026 | Undisclosed · Equity | 扬州未来光锥股权投资合伙企业（有限合伙） | No source link |
Evidence Wujinfangzhou raises an undisclosed amount in equity financingOn 2026-07-07, according to Xiniu Data, Wujinfangzhou completed equity financing for an undisclosed amount. Investors were Yangzhou Weilaiguangzhuiguquan Investment Partnership (Limited Partnership). The company is a developer of AI-powered anti-aging drugs. Translated source brief, not a quotation. Check the original before citing. Sources · 0
| |||
| May 18, 2026 | Tens of millions of RMB · Seed | Boyu Venture Capital, 九合创投, 扬州未来光锥股权投资合伙企业（有限合伙）, 砺思资本 | No source link |
Evidence Wujinfangzhou raises tens of millions of RMB in seed financingOn 2026-05-18, according to Xiniu Data, Wujinfangzhou completed seed financing, raising tens of millions of RMB. Investors were lead investor Monolith, participating investor Boyu Capital, participating investor Jiuhe Venture Capital, participating investor Weilaiguangzhui. The company is a developer of AI-powered anti-aging drugs. Translated source brief, not a quotation. Check the original before citing. Sources · 0
| |||
Select ▸ on a row to see its source brief and links.
Valuation
Amounts as reported; USD estimates shown only when they matchListed 3 valuation records.
No chartable valuation estimates yet.
3 listed records lack a clear date or positive USD estimate for the chart.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| Jul 17, 2026 | — · Seed | Boyu Venture Capital, 九合创投, 星连资本, 砺思资本 | No source link |
Evidence Wujinfangzhou raises tens of millions of RMB in seed financingOn 2026-07-17, according to Xiniu Data, Wujinfangzhou completed seed financing, raising tens of millions of RMB. Investors were lead investor Jiuhe Venture Capital, participating investor Monolith, participating investor Boyu Capital, participating investor Xinglian Capital. The company is a developer of AI-powered anti-aging drugs. Translated source brief, not a quotation. Check the original before citing. Sources · 0
| |||
| Jul 7, 2026 | — · Equity | 扬州未来光锥股权投资合伙企业（有限合伙） | No source link |
Evidence Wujinfangzhou raises an undisclosed amount in equity financingOn 2026-07-07, according to Xiniu Data, Wujinfangzhou completed equity financing for an undisclosed amount. Investors were Yangzhou Weilaiguangzhuiguquan Investment Partnership (Limited Partnership). The company is a developer of AI-powered anti-aging drugs. Translated source brief, not a quotation. Check the original before citing. Sources · 0
| |||
| May 18, 2026 | — · Seed | Boyu Venture Capital, 九合创投, 扬州未来光锥股权投资合伙企业（有限合伙）, 砺思资本 | No source link |
Evidence Wujinfangzhou raises tens of millions of RMB in seed financingOn 2026-05-18, according to Xiniu Data, Wujinfangzhou completed seed financing, raising tens of millions of RMB. Investors were lead investor Monolith, participating investor Boyu Capital, participating investor Jiuhe Venture Capital, participating investor Weilaiguangzhui. The company is a developer of AI-powered anti-aging drugs. Translated source brief, not a quotation. Check the original before citing. Sources · 0
| |||
Select ▸ on a row to see its source brief and links.
Revenue
Amounts as reported; USD estimates shown only when they matchNo revenue records are listed yet.
No revenue rows to list.
Team, products & investors
Explore
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
AI抗衰老药物研发商